Myelodysplastic syndromes (MDS) are clearly a disease of the elderly, the median age of patients being 70 years. Almost one-third of patients will progress to acute myeloid leukaemia (AML). These clonal heterogeneous stem cell disorders are characterised by the clinical presentation of variable cytopenias despite a generally cellular and dysplastic marrow. Cytogenetic abnormalities most commonly affecting chromosomes 5, 7, 8 and 20 are present in approximately 40-50% of MDS patients at diagnosis and greatly affect prognosis and survival.
a proliferative advantage over its neighbours. The proliferative advantage, although slight, could eventually lead to clonal expansion and, ultimately, a state of monoclonal haematopoiesis that is intuitively more susceptible to a malignant transformation than a system with polyclonal haematopoiesis. In fact, up to 40% women over 65 years of age have been found to have monoclonal haematopoiesis without manifesting any evidence of disease, and it is well known that MDS is more common in the elderly. In summary, therefore, clonal expansion of a haematopoietic stem cell could begin as a perturbation in its microenvironment, progressing towards mutations in the cell itself and eventual transformation to a malignant state.
Excessive Proliferation-Apoptosis Mediated Through Cytokines
In the early 1990s, excessive proliferation and excessive apoptosis were recognised as biological characteristics that were common to all types of MDS and explained the inconsistency of finding cytopenias in the presence of a cellular bone marrow. 1 Furthermore, it was shown that the apoptosis may be largely mediated by a set of pro-inflammatory cytokines, the prime initiator of the cascade being tumour necrosis factor alpha (TNF-α). The paradox here was the existence of clonal expansion if the MDS cells are prone to die prematurely by programmed cell death. We proposed a model to explain this paradox that could result from the dual actions of a cytokine such as TNF-α that stimulates the proliferation of and hence clonal expansion in early progenitor cells, but induces apoptosis in their maturing progeny. 2, 3 Furthermore, it is clear that the propensity to undergo apoptosis is not something that is parcelled out equally to all daughter cells in the clone. In fact, the spectrum of sensitivity to apoptose ranges from cells that are highly sensitive to a subset of mature peripheral blood granulocytes whose resistance to undergoing apoptosis is more than even that of granulocytes from normal individuals.
In summary, therefore, a haematopoietic stem cell that has developed a proliferative advantage over its neighbours, for an as yet unexplained reason, undergoes clonal expansion. The progeny of this clone has a spectrum of sensitivity for premature apoptosis, with some daughters dying early in the marrow while others with resistance reach the peripheral blood as mature granulocytes. A major mediator of the excessive apoptosis appears to be the cascade of pro-inflammatory cytokines.
Finally, excessive apoptosis, which was the first unifying biological link between the different types of MDS, and proliferation are tightly controlled by the p53 tumour-suppressor proteins. Previous work had failed to pinpoint the precise mechanistic basis of this association between p53 and apoptosis in MDS; however, thanks to recent dramatic technological improvements, entirely unexpected new areas of research are emerging that both explain the molecular basis of some of these biological insights and provide further proof of thematic cohesion between the syndromes of myelodysplasia. were found to be remarkably similar. expression was slightly increased in 5q patients, there was no significant difference between the other two miRNAs in the MDS patients versus controls. Additionally, a strong increase in miRNA-125b was found in bone marrow cells from patients diagnosed with AML and MDS containing a rare but consistent t(2;11)(p21;q23) karyotype. 14 In vitro studies showed that overexpression of miRNA-125b disrupted Myelodysplastic Syndromes -Unexpected Insights Stimulate the Biological Landscape
Micro
CD34 + cell differentiation and also inhibited terminal monocyte and granulocyte differentiation in cell lines. Most recently, Hussein et al. 15 looked at expression levels of these haematopoiesis-associated miRNAs (-150, -155, -221 and -222) in marrow cells of 52 MDS patients of all subtypes (eight with isolated del(5q)) compared with controls. Surprisingly, miRNA-150 increased expression was the only perturbation detected and this was confined to patients with del(5q). The expression of MYB, one of the targets of miRNA-150, was found to be inversely correlated with miRNA-150 expression, suggesting that decreased levels of MYB, a main component of erythropoiesis, 16 may contribute to the anaemia found in 5q-syndrome patients.
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